Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CrystalPlex
Pittsburgh, Pennsylvania, USA
- Ownership
- Private
- Employees
- ~10
- Development stage
- Other
01
Overview
CrystalPlex is a biotechnology company specializing in the development and manufacture of advanced nanocrystal technologies, specifically quantum dots. The company's proprietary technology enables high-level multiplexing for molecular diagnostics, flow cytometry, and high-throughput screening. Their products, such as the CrystalPlex nanocrystals, are designed to provide stable, bright, and narrow-spectrum fluorescence for precise detection of multiple biomarkers simultaneously. By offering a wide range of emission wavelengths, CrystalPlex supports researchers and clinicians in complex biological analysis and drug discovery.
- Modalities
- Nanoparticle
- Industry
- Chemicals & Materials
Beyond the preview
Go deeper on CrystalPlex.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CrystalPlex.